drugset / Trial / NCT01092403
Safety, Tolerability and Clinical Activity of ASM-024 in Subjects With Mild Allergic Asthma
RandomizedCrossoverDouble-blindTreatment
Summary
The study will assess the safety, tolerability and clinical activity of ASM-024 in subjects with mild allergic asthma.
Timeline
- Start
- 2010-04
- Primary completion
- 2011-12
- Completion
- 2012-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ASM-024 | Unknown | 50 mg | Inhaled |
| Subject | ASM-024 | Unknown | 200 mg | Inhaled |